Factors Associated With Diabetes Care Quality Among Patients With Schizophrenia in Ontario, Canada.


Journal

Psychiatric services (Washington, D.C.)
ISSN: 1557-9700
Titre abrégé: Psychiatr Serv
Pays: United States
ID NLM: 9502838

Informations de publication

Date de publication:
01 02 2020
Historique:
pubmed: 21 11 2019
medline: 31 12 2020
entrez: 21 11 2019
Statut: ppublish

Résumé

The authors investigated demographic, clinical, and service-utilization factors that affected the quality of diabetes care among patients with schizophrenia. This was a retrospective cohort study of adults with schizophrenia and diabetes (N=26,259) in Ontario, Canada. Quality of care was based on receipt of three guideline-concordant diabetes care procedures between 2011 and 2013. A cumulative logit regression model was used to determine characteristics associated with optimal testing. Factors associated with optimal diabetes testing included more frequent outpatient psychiatrist visits (odds ratio [OR]=1.28, 95% confidence interval [CI]=1.20-1.37) and primary care visits for nonmental health reasons (OR=2.10, 95% CI=1.85-2.39). High-frequency primary care visits for mental health reasons, any hospitalizations, and emergency visits for mental health reasons were associated with lower odds of testing. Diabetes quality of care may be contingent on receipt of medically focused primary care, psychiatric stability, and receipt of specialist psychiatric care.

Identifiants

pubmed: 31744427
doi: 10.1176/appi.ps.201900009
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

188-191

Subventions

Organisme : CIHR
Pays : Canada

Auteurs

Jonathan H Hsu (JH)

Department of Psychiatry, Faculty of Medicine (Hsu), Institute of Health Policy, Management and Evaluation (Stukel), and Department of Family and Community Medicine (Kiran), all at University of Toronto, Toronto; Institute for Clinical Evaluative Sciences, Toronto (Calzavara, Vigod, Stukel, Kiran, Kurdyak); Women's College Research Institute, Women's College Hospital, Toronto (Vigod); Family Health Team, St. Michael's Hospital, Toronto (Kiran); Centre for Addiction and Mental Health, Toronto (Hsu, Kurdyak).

Andrew Calzavara (A)

Department of Psychiatry, Faculty of Medicine (Hsu), Institute of Health Policy, Management and Evaluation (Stukel), and Department of Family and Community Medicine (Kiran), all at University of Toronto, Toronto; Institute for Clinical Evaluative Sciences, Toronto (Calzavara, Vigod, Stukel, Kiran, Kurdyak); Women's College Research Institute, Women's College Hospital, Toronto (Vigod); Family Health Team, St. Michael's Hospital, Toronto (Kiran); Centre for Addiction and Mental Health, Toronto (Hsu, Kurdyak).

Simone Vigod (S)

Department of Psychiatry, Faculty of Medicine (Hsu), Institute of Health Policy, Management and Evaluation (Stukel), and Department of Family and Community Medicine (Kiran), all at University of Toronto, Toronto; Institute for Clinical Evaluative Sciences, Toronto (Calzavara, Vigod, Stukel, Kiran, Kurdyak); Women's College Research Institute, Women's College Hospital, Toronto (Vigod); Family Health Team, St. Michael's Hospital, Toronto (Kiran); Centre for Addiction and Mental Health, Toronto (Hsu, Kurdyak).

Therese A Stukel (TA)

Department of Psychiatry, Faculty of Medicine (Hsu), Institute of Health Policy, Management and Evaluation (Stukel), and Department of Family and Community Medicine (Kiran), all at University of Toronto, Toronto; Institute for Clinical Evaluative Sciences, Toronto (Calzavara, Vigod, Stukel, Kiran, Kurdyak); Women's College Research Institute, Women's College Hospital, Toronto (Vigod); Family Health Team, St. Michael's Hospital, Toronto (Kiran); Centre for Addiction and Mental Health, Toronto (Hsu, Kurdyak).

Tara Kiran (T)

Department of Psychiatry, Faculty of Medicine (Hsu), Institute of Health Policy, Management and Evaluation (Stukel), and Department of Family and Community Medicine (Kiran), all at University of Toronto, Toronto; Institute for Clinical Evaluative Sciences, Toronto (Calzavara, Vigod, Stukel, Kiran, Kurdyak); Women's College Research Institute, Women's College Hospital, Toronto (Vigod); Family Health Team, St. Michael's Hospital, Toronto (Kiran); Centre for Addiction and Mental Health, Toronto (Hsu, Kurdyak).

Paul Kurdyak (P)

Department of Psychiatry, Faculty of Medicine (Hsu), Institute of Health Policy, Management and Evaluation (Stukel), and Department of Family and Community Medicine (Kiran), all at University of Toronto, Toronto; Institute for Clinical Evaluative Sciences, Toronto (Calzavara, Vigod, Stukel, Kiran, Kurdyak); Women's College Research Institute, Women's College Hospital, Toronto (Vigod); Family Health Team, St. Michael's Hospital, Toronto (Kiran); Centre for Addiction and Mental Health, Toronto (Hsu, Kurdyak).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH